Kazia Therapeutics Statistics

NASDAQ: KZIAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.06+0.235 (+2.66%)

Market open · Delayed 15 min · as of Oct 9, 11:59 AM ET

Kazia Therapeutics by the numbers

Kazia Therapeutics has a market capitalization of $103.5 million based on 11.43M shares outstanding. With trailing EPS of $-6.85, Kazia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.8% below its 50-day average and 13.4% below its 200-day average.

Average daily trading volume is 262.41K shares, or about $2.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

KZIA valuation vs. peer median

KZIA compared with the median of 8 peer companies
Metric	KZIA	Peer median	Difference
Market cap	$103.47M	$102.04M	+1%
Avg. volume	262.41K	259.96K	+1%

Peer median across 8 companies: AARD, ANIX, PLYX, BMEA, CRBP, CPIX, OKUR, MIST.

Valuation

Market cap: $103.47M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-6.85
Shares outstanding: 11.43M

Price and trading

Previous close: 8.82
Open: 8.89
Day range: 8.75 – 9.08
52-week range: 4.86 – 17.40
52-week change: +23.18%
50-day moving average: 11.89
200-day moving average: 10.46
Beta: —
Volume: 29.43K
Average volume: 262.41K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: May 28, 2025

Additional statistics

Market Cap: 103.47M
Forward Pe: -760.71
Eps: -6.85
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 17.40
Week52 Low: 4.86
Avg Volume: 262.41K
Shares Outstanding: 11.43M
Ma50: 11.89
Ma200: 10.46
Earnings Date: May 28, 2025
Pct From52w High: -47.96%
Pct From52w Low: 86.32%